[go: up one dir, main page]

SI2203187T1 - Konstrukti, ki vsebujejo hkratne ekspresijske kasete za zdravljenje raka - Google Patents

Konstrukti, ki vsebujejo hkratne ekspresijske kasete za zdravljenje raka

Info

Publication number
SI2203187T1
SI2203187T1 SI200830831T SI200830831T SI2203187T1 SI 2203187 T1 SI2203187 T1 SI 2203187T1 SI 200830831 T SI200830831 T SI 200830831T SI 200830831 T SI200830831 T SI 200830831T SI 2203187 T1 SI2203187 T1 SI 2203187T1
Authority
SI
Slovenia
Prior art keywords
cancer therapy
expression cassettes
containing multiple
constructs containing
multiple expression
Prior art date
Application number
SI200830831T
Other languages
English (en)
Inventor
Avraham Hochberg
Doron Amit
Original Assignee
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. filed Critical Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
Publication of SI2203187T1 publication Critical patent/SI2203187T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200830831T 2007-10-25 2008-10-23 Konstrukti, ki vsebujejo hkratne ekspresijske kasete za zdravljenje raka SI2203187T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98244207P 2007-10-25 2007-10-25
EP08842129A EP2203187B1 (en) 2007-10-25 2008-10-23 Constructs containing multiple expression cassettes for cancer therapy
PCT/IL2008/001405 WO2009053982A1 (en) 2007-10-25 2008-10-23 Constructs containing multiple expression cassettes for cancer therapy

Publications (1)

Publication Number Publication Date
SI2203187T1 true SI2203187T1 (sl) 2013-01-31

Family

ID=40266127

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830831T SI2203187T1 (sl) 2007-10-25 2008-10-23 Konstrukti, ki vsebujejo hkratne ekspresijske kasete za zdravljenje raka

Country Status (14)

Country Link
US (2) US9173964B2 (sl)
EP (1) EP2203187B1 (sl)
JP (1) JP5486502B2 (sl)
KR (1) KR101539796B1 (sl)
CN (1) CN101903046B (sl)
AU (1) AU2008315409B2 (sl)
BR (1) BRPI0818937B8 (sl)
CA (1) CA2703774C (sl)
CY (1) CY1113659T1 (sl)
ES (1) ES2394129T3 (sl)
IL (1) IL205048A (sl)
RU (1) RU2487165C2 (sl)
SI (1) SI2203187T1 (sl)
WO (1) WO2009053982A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658155B2 (en) 2010-12-27 2014-02-25 The Jackson Laboratory Compositions and methods relating to non-human animals modified to promote production of selected gametes
WO2016178233A1 (en) 2015-05-05 2016-11-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Nucleic acid-cationic polymer compositions and methods of making and using the same
CN105039404A (zh) * 2015-06-25 2015-11-11 重庆高圣生物医药有限责任公司 一种靶向肿瘤的双调控重组腺相关病毒包装系统
US11911499B2 (en) 2019-11-07 2024-02-27 Resurge Therapeutics, Inc. System and method for prostate treatment
US11957654B2 (en) 2022-01-29 2024-04-16 Resurge Therapeutics, Inc. Treating benign prostatic hyperplasia
US11974979B2 (en) 2022-01-29 2024-05-07 Resurge Therapeutics, Inc. Treatments for benign prostatic hyperplasia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108879A (en) 1994-03-07 2000-08-31 Yissum Res Dev Co Diagnostic assay for malignancies using the H19 gene and kit
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US7041654B2 (en) * 1997-10-03 2006-05-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for inducing tumor-specific cytotoxicity
US6087164A (en) 1997-10-03 2000-07-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for inducing tumor-specific cytotoxicity
WO2004024957A2 (en) 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis
AU2003291631A1 (en) 2002-10-03 2004-04-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for regulating expression genes
TW200613554A (en) * 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
ES2435774T3 (es) 2005-07-07 2013-12-23 Yissum Research Development Company, Of The Hebrew University Of Jerusalem Agentes de ácido nucleico para la regulación negativa de H19, y métodos de uso del mismo
JP2009508516A (ja) * 2005-09-22 2009-03-05 イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム 核酸構築物、薬剤組成物、及び癌治療のためのその使用方法
WO2008087642A2 (en) 2007-01-16 2008-07-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acid constructs and methods for specific silencing of h19
WO2008099396A1 (en) 2007-02-15 2008-08-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of h19-silencing nucleic acid agents for treating restenosis

Also Published As

Publication number Publication date
CA2703774A1 (en) 2009-04-30
ES2394129T3 (es) 2013-01-22
BRPI0818937A2 (pt) 2016-10-11
EP2203187B1 (en) 2012-08-29
US10004813B2 (en) 2018-06-26
RU2010119173A (ru) 2011-11-27
BRPI0818937B8 (pt) 2021-05-25
RU2487165C2 (ru) 2013-07-10
AU2008315409B2 (en) 2013-10-31
CY1113659T1 (el) 2016-06-22
WO2009053982A1 (en) 2009-04-30
EP2203187A1 (en) 2010-07-07
IL205048A (en) 2015-04-30
AU2008315409A1 (en) 2009-04-30
IL205048A0 (en) 2010-11-30
US9173964B2 (en) 2015-11-03
BRPI0818937B1 (pt) 2019-11-26
US20100256225A1 (en) 2010-10-07
KR20100100810A (ko) 2010-09-15
JP5486502B2 (ja) 2014-05-07
JP2011500080A (ja) 2011-01-06
CN101903046A (zh) 2010-12-01
KR101539796B1 (ko) 2015-07-27
US20160015834A1 (en) 2016-01-21
CN101903046B (zh) 2013-02-20
CA2703774C (en) 2019-05-21

Similar Documents

Publication Publication Date Title
HRP20181385T1 (hr) Ciljanje abcb5 za terapiju raka
GB0807263D0 (en) Formulations for cancer treatment
EP2225254A4 (en) THERAPEUTIC CARE TREATMENTS
EP2321009B8 (en) Radiotherapy apparatus
ZA201005248B (en) 4-pyridinone compounds and their use for cancer
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
GB2452993B (en) Tissue cassette dispensing apparatus
HUE038611T2 (hu) Vitiligo terápia
GB0719518D0 (en) Therapy
IL205048A0 (en) Constructs containing multiple expression cassettes for cancer therapy
GB0707556D0 (en) Treatment for cancer
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy
AU2007900499A0 (en) Therapy for vitiligo
AU2008902090A0 (en) Cancer Therapy
IL210247A0 (en) Ccl20 - specific antibodies for cancer therapy
GB0706538D0 (en) Cancer therapeutic
AU2008901461A0 (en) Therapy for vitiligo
GB2487507B (en) Tissue cassette dispensing apparatus
AU2007906570A0 (en) Compounds for treating cancer
HK1162700A (en) Individualized cancer treatment
GB0706537D0 (en) Transcutaneous cancer therapeutic
GB0723503D0 (en) Cancer treatment
GB0700493D0 (en) Cancer treatment
GB0604794D0 (en) Spisulosine compounds for use in cancer therapy